Apogee Therapeutics CMO Executes Stock Option Exercise and Subsequent Share Sale
Carl Dambkowski, the Chief Medical Officer at Apogee Therapeutics, Inc. (NASDAQ:APGE), has completed a series of transactions involving the company's common stock. On May 6, 2026, Mr. Dambkowski exercised stock options to acquire shares and subsequently sold a portion of his holdings, totaling $462,784 in sales. These moves occurred within the cont…